Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Baxter
Colorcon
Federal Trade Commission
McKesson
US Department of Justice
Argus Health
Mallinckrodt

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,639,436

« Back to Dashboard

Summary for Patent: 4,639,436
Title: Antidiabetic 3,4,5-trihydroxypiperidines
Abstract:The invention includes certain 3,4,5-trihydroxypiperidine compounds, methods for their preparation, compositions containing said 3,4,5-trihydroxypiperidine compounds and methods for the use of said compounds and compositions. The subject matter of the invention is useful against diabetes, hyperlipaemia and adiposity as well as in animal nutrition.
Inventor(s): Junge; Bodo (Wuppertal, DE), Krause; Hans P. (Wuppertal, DE), Muller; Lutz (Wuppertal, DE), Puls; Walter (Wuppertal, DE)
Assignee: Bayer Aktiengesellschaft (Leverkusen, DE)
Application Number:05/936,280
Patent Claim Types:
see list of patent claims
Compound; Use; Composition; Formulation; Dosage form; Delivery;

Drugs Protected by US Patent 4,639,436

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,639,436

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany27387173Aug 27, 1977
Germany27580252Dec 24, 1977

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Farmers Insurance
Argus Health
Federal Trade Commission
Accenture
Daiichi Sankyo
Dow
Julphar
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.